A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Public ClinicalTrials.gov record NCT07085091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, First in Human, Open-Label Multicenter Study to Evaluate ALX2004, an Antibody Drug Conjugate Targeting EGFR in Participants With Advanced or Metastatic Select Solid Tumors
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 1, First in Human, Open-Label Multicenter Study to Evaluate ALX2004, an Antibody Drug Conjugate Targeting EGFR in Participants with Advanced or Metastatic Select Solid Tumors
Study identification
- NCT ID
- NCT07085091
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 170 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 18, 2025 (Actual)
- Primary completion
- Jun 2027 (Estimated)
- Completion
- Dec 2027 (Estimated)
- Last update posted
- Sep 30, 2026
2025 – 2027
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ALX Center 9 | La Jolla | California | 92037 | Recruiting |
| ALX Center 11 | Santa Monica | California | 90404 | Recruiting |
| ALX Center 7 | Tampa | Florida | 33612 | Recruiting |
| ALX Center 8 | Farmington Hills | Michigan | 48334 | Recruiting |
| ALX Center 3 | Grand Rapids | Michigan | 49546 | Recruiting |
| ALX Center 12 | Morristown | New Jersey | 07962 | Recruiting |
| ALX Center 10 | Columbus | Ohio | 43210 | Recruiting |
| ALX Center 6 | Portland | Oregon | 97213 | Recruiting |
| ALX Center 5 | Houston | Texas | 77030 | Recruiting |
| ALX Center 4 | West Valley City | Utah | 84119 | Recruiting |
| ALX Center 2 | Fairfax | Virginia | 22031 | Recruiting |
| ALX Center 1 | Spokane | Washington | 99208 | Withdrawn |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07085091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07085091 live on ClinicalTrials.gov.